Clinical trial NCT05538468: Kinesiophobia in Stroke Patients and Affecting Factors
Official title: Investigation of the Relationship Between Depression, Postural Control, Pain, Affected Side and Kinesiophobia in Stroke Patients
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Kinesiophobia
Stroke Patients
Keywords: Kinesiophobia
stroke patients
Pain
Postural control
Depression
Lead sponsor: Inonu University
Sponsor class: OTHER
First posted: 2022-09-13
Enrollment: 30
Sex: ALL
Minimum age (years): 25
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: 30 patients who were level 2 and above according to the Functional Ambulation Classification were included in the study.

Brief summary: It was aimed to determine the presence of kinesiophobia that will affect the treatment in stroke patients and to investigate the relationship between these factors and kinesiophobia by examining factors such as postural control, depression, pain, and affected side that may cause kinesiophobia.

Detailed description: Objective: This study was planned to investigate the relationship between depression, postural control, pain, affected side and kinesiophobia in stroke patients. Material and Method: Thirty patients aged between 25-70 years who had a stroke at the earliest 6 months and who Functional Ambulation Scale were level 2 and above according to the were included in the study. Patients were selected by random sampling method from the relevant population. Demographic data were obtained from all subjects who met the inclusion criteria. Patients were evaluated Kinesiophobia scores (Tampa Kinesiophobia Scale (TKÖ) and VAS-Kinesiophobia Assessment), depression severity (Beck Depression Inventory), postural control loss (PASS) and pain severity (VAS).

Eligibility criteria: Inclusion Criteria:

* individuals who were diagnosed with hemiplegia or hemiparesis after SVO,
* at least 6 months after SVO,
* who were Level 2 and above according to the Functional Ambulation Classification,
* who wanted to participate in the study voluntarily

Exclusion Criteria:

* Anyone with a major neurological or rheumatological pathology (polyneuropathy, parkinson's, multiple sclerosis, rheumatoid arthritis, etc.)
* Affecting the musculoskeletal system other than stroke
* Who does not allow mental evaluation, cannot fill in the scales,
* is illiterate, has aphasia, has a history of falling,
* have any cardiac problems,
* amputation in the lower extremities,
* those with active malignancy and related chemo/radiotherapy,
* the presence of accompanying lower motor neuron or peripheral nerve lesion,
* any musculoskeletal problem and related pain (lumbar disc herniation, meniscus, etc.),
* ındividuals with shoulder subluxation, shoulder-hand syndrome
* those who refused to participate in the study

Primary outcomes:
measure: Kinesiophobia Assessment
timeFrame: 6 mounts
measure: Kinesiophobia Assessment
timeFrame: 6 mounts
measure: Pain Assessment
timeFrame: 6 mounts
measure: Postural Control Assessment
timeFrame: 6 mounts
measure: Depression Severity Assessment
timeFrame: 6 mounts
Secondary outcomes:
Other outcomes:
Locations:
city: Malatya
country: Turkey
facility: Inonu University
Study officials:
References: